These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 21767219)
1. Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Markou A; Liang Y; Lianidou E Clin Chem Lab Med; 2011 Oct; 49(10):1591-603. PubMed ID: 21767219 [TBL] [Abstract][Full Text] [Related]
2. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer. Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820 [TBL] [Abstract][Full Text] [Related]
3. Cell-free microRNAs as diagnostic, prognostic, and predictive biomarkers for lung cancer. Zandberga E; Kozirovskis V; Ābols A; Andrējeva D; Purkalne G; Linē A Genes Chromosomes Cancer; 2013 Apr; 52(4):356-69. PubMed ID: 23404859 [TBL] [Abstract][Full Text] [Related]
4. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification. Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018 [TBL] [Abstract][Full Text] [Related]
5. Clinical implication of microrna for lung cancer. Wang Y; Zhang X; Liu L; Li H; Yu J; Wang C; Ren X Cancer Biother Radiopharm; 2013 May; 28(4):261-7. PubMed ID: 23496233 [TBL] [Abstract][Full Text] [Related]
6. Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features. Capodanno A; Boldrini L; Proietti A; Alì G; Pelliccioni S; Niccoli C; D'Incecco A; Cappuzzo F; Chella A; Lucchi M; Mussi A; Fontanini G Int J Oncol; 2013 Sep; 43(3):765-74. PubMed ID: 23820752 [TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer. Zhou Q; Huang SX; Zhang F; Li SJ; Liu C; Xi YY; Wang L; Wang X; He QQ; Sun CC; Li DJ Cell Prolif; 2017 Dec; 50(6):. PubMed ID: 28990243 [TBL] [Abstract][Full Text] [Related]
8. MiR-142-3p functions as a potential tumor suppressor directly targeting HMGB1 in non-small-cell lung carcinoma. Xiao P; Liu WL Int J Clin Exp Pathol; 2015; 8(9):10800-7. PubMed ID: 26617792 [TBL] [Abstract][Full Text] [Related]
9. Deregulated expression of miR-21, miR-143 and miR-181a in non small cell lung cancer is related to clinicopathologic characteristics or patient prognosis. Gao W; Yu Y; Cao H; Shen H; Li X; Pan S; Shu Y Biomed Pharmacother; 2010 Jul; 64(6):399-408. PubMed ID: 20363096 [TBL] [Abstract][Full Text] [Related]
10. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis. Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218 [TBL] [Abstract][Full Text] [Related]
11. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma. Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis. Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443 [TBL] [Abstract][Full Text] [Related]
13. miRNAs as Biomarkers and Therapeutic Targets in Non-Small Cell Lung Cancer: Current Perspectives. Florczuk M; Szpechcinski A; Chorostowska-Wynimko J Target Oncol; 2017 Apr; 12(2):179-200. PubMed ID: 28243959 [TBL] [Abstract][Full Text] [Related]
14. MicroRNAs in non-small cell lung cancer: current status and future therapeutic promises. Cortinovis D; Monica V; Pietrantonio F; Ceresoli GL; La Spina CM; Wannesson L Curr Pharm Des; 2014; 20(24):3982-90. PubMed ID: 24138721 [TBL] [Abstract][Full Text] [Related]
15. miRNAs, a potential target in the treatment of Non-Small-Cell Lung Carcinomas. Malleter M; Jacquot C; Rousseau B; Tomasoni C; Juge M; Pineau A; Sakanian V; Roussakis C Gene; 2012 Sep; 506(2):355-9. PubMed ID: 22732573 [TBL] [Abstract][Full Text] [Related]
16. microRNAs and lung cancer: tumors and 22-mers. Du L; Pertsemlidis A Cancer Metastasis Rev; 2010 Mar; 29(1):109-22. PubMed ID: 20130964 [TBL] [Abstract][Full Text] [Related]
17. Molecular predictive and prognostic markers in non-small-cell lung cancer. Coate LE; John T; Tsao MS; Shepherd FA Lancet Oncol; 2009 Oct; 10(10):1001-10. PubMed ID: 19796752 [TBL] [Abstract][Full Text] [Related]
18. Role of microRNAs in lung cancer: microRNA signatures in cancer prognosis. Boeri M; Pastorino U; Sozzi G Cancer J; 2012; 18(3):268-74. PubMed ID: 22647364 [TBL] [Abstract][Full Text] [Related]
19. MicroRNA-139-5p inhibits cell proliferation and invasion by targeting insulin-like growth factor 1 receptor in human non-small cell lung cancer. Xu W; Hang M; Yuan CY; Wu FL; Chen SB; Xue K Int J Clin Exp Pathol; 2015; 8(4):3864-70. PubMed ID: 26097570 [TBL] [Abstract][Full Text] [Related]
20. Down-regulation of microRNA-181b is a potential prognostic marker of non-small cell lung cancer. Yang J; Liu H; Wang H; Sun Y Pathol Res Pract; 2013 Aug; 209(8):490-4. PubMed ID: 23827213 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]